Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Medtronic’s Extravascular ICD Stops Ventricular Arrhythmias In Pilot Trial

May 20 2019

• By Reed Miller

FRIDLEY, MN/USA - JUNE 23, 2014: Medtronic corporate headquarters campus. Medtronicis the world's fourth largest medical device company and is a Fortune 500 company. - Image — • Source: shutterstock.com

Related Content

HRS 2016 ROUND-UP: Medtronic Unveils New “Extravascular ICD”

May 12 2016

UNTOUCHED Trial Shows Low Complication Rate With Boston Scientific’s Emblem S-ICD

May 20 2019

HRS 2017: Medtronic And Boston Scientific's Less-Invasive CRM Devices Perform As Hoped In Real-World Registries

May 14 2017

Related Companies

Medtronic plc

Additional Topics

Clinical Trials Innovation Research & Development Cardiovascular Cardiology Medical Device

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window